⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ALDX News
Aldeyra Therapeutics, Inc.
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Aldeyra Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - ALDX
accessnewswire.com
ALDX
Pomerantz LLP Issues Alert Regarding Shareholder Class Action Against Aldeyra Therapeutics, Inc. – ALDX
accessnewswire.com
ALDX
Bragar Eagel & Squire, P.C. Encourages Aldeyra Therapeutics, Inc. Investors with Large Losses to Contact the Firm Regarding Their Rights Before May 29th
globenewswire.com
ALDX
ALDX Investors Have Opportunity to Lead Aldeyra Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
globenewswire.com
ALDX
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 29, 2026 in Aldeyra Therapeutics, Inc. Lawsuit - ALDX
globenewswire.com
ALDX
ALDX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aldeyra Therapeutics, Inc. Investors Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
ALDX
Pomerantz LLP Informs Shareholders of Class Action Against Aldeyra Therapeutics, Inc. – ALDX
accessnewswire.com
ALDX
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Aldeyra Therapeutics, Inc. Of Class Action Lawsuit and Upcoming Deadlines - ALDX
prnewswire.com
ALDX
REMINDER: Aldeyra Therapeutics, Inc. Investors With Significant Losses Must Act By May 29, 2026
globenewswire.com
ALDX
ALDX Investors Have Opportunity to Lead Aldeyra Therapeutics, Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm
prnewswire.com
ALDX